ENDRA Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for ENDRA Life Sciences (NDRA).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$25Upside to Avg. PT+297.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 1, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$27→$25
Dec 8, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$38→$30
Sep 22, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$46→$38
May 30, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$50→$46
Apr 21, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$75→$50
Jun 7, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$10→$8

More with Benzinga EdgeGet Access

Analyst Ratings News

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $25

Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target from $27 to $25.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $30

Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target from $38 to $30.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $38

Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target from $46 to $38.

Benzinga Newsdesk

Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $46

Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target from $50 to $46.

Benzinga Newsdesk

ENDRA Life Sciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

ENDRA Life Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $25

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $30

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $38

Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $46

People Also Watch

People Also Watch

ENDRA Life Sciences Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

ENDRA Life Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

PROAscendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $25

PROAscendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $30

PROAscendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $38

Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday

PROAscendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $46

People Also Watch

People Also Watch

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $25

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $30

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $38

PRO
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $46